TORVUTATUG SAMROTECAN
UNII E5QZ8ZF3HE

Substance Identification & Data

This profile provides standardized clinical and technical data for Torvutatug Samrotecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E5QZ8ZF3HE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2975630-26-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

E5QZ8ZF3HE

CAS Registry Number

2975630-26-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TORVUTATUG SAMROTECAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C200057

National Cancer Institute reference terminology for clinical and research data.

INN ID

13421

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-25

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Torvutatug Samrotecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TORVUTATUG SAMROTECAN

Common Names & Synonyms

AZD 5335 [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN FOLATE RECEPTOR .ALPHA.) (HUMAN MONOCLONAL INT-019 .GAMMA.1-CHAIN), COMPLEX WITH HUMAN MONOCLONAL INT-019 .KAPPA.-CHAIN, DIMER, OCTAKIS(THIOETHER) WITH N-(31-(2,5-DIHYDRO-2,5-DIOXO-1H-PYRROL-1-YL)-1,29-DIOXO-4,7,10,13,16,19,22,25-OCTAOXA-28-AZAHENTRIACONT-1-YL)-L-VALYL-N-((9S)-9-ETHYL-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-4-YL)-L-ALANINAMIDE

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS FOLR1 (FOLATE RECEPTOR 1, FOLATE RECEPTOR ALPHA, FR-ALPHA, ADULT FOLATE-BINDING PROTEIN, FBP, OVARIAN TUMOR-ASSOCIATED ANTIGEN MOV18)), HOMO SAPIENS MONOCLONAL ANTIBODY; CONJUGATED ON EIGHT CYSTEINYL RESIDUES TO SAMROTECAN, COMPRISING A LINKER AND A CAMPTOTHECIN DERIVATIVE (EXATECAN) (TORVUTATUG SAMROTECAN)

TORVUTATUG SAMROTECAN [INN]

TORVUTATUG SAMROTECAN [USAN]